日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting S100A9-mediated inflammation: a novel therapeutic approach for CLL

靶向S100A9介导的炎症:慢性淋巴细胞白血病的一种新型治疗方法

Uriepero-Palma, Angimar; Márquez, Maria Elena; Payque, Eugenia; Mediavilla-Varela, Melanie; Gamal, Wael; Maharaj, Kamira; Powers, John; Chavez, Julio; Eksioglu, Erika; Sernbo, Sandra; Palacios, Florencia; Querol-Rivas, Juliana; Ortega, Claudia; Uria, Rita; Santos, Gimena Dos; Oliver, Carolina; Landoni, Ana Inés; Sahakian, Eva; Oppezzo, Pablo; Pinilla-Ibarz, Javier

Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model.

减轻 CLL 中的 T 细胞线粒体功能障碍以增强 CAR T 细胞疗法:在免疫功能健全的模型中进行评估

Gamal Wael, Goedhart Nienke B, Simon-Molas Helga, Mediavilla-Varela Melanie, Uriepero-Palma Angimar, Peters Fleur S, Maharaj Kamira, Chavez Julio C, Powers John, Obermayer Alyssa, Shaw Timothy I, Conejo-Garcia José R, Rodriguez Paulo C, Sahakian Eva, Pinilla-Ibarz Javier, Kater Arnon P

Impact of mitochondrial metabolism on T-cell dysfunction in chronic lymphocytic leukemia

线粒体代谢对慢性淋巴细胞白血病中T细胞功能障碍的影响

Gamal, Wael; Mediavilla-Varela, Melanie; Kunta, Vishaal; Sahakian, Eva; Pinilla-Ibarz, Javier

Aspergillus flavus with Mycovirus as an Etiologic Factor for Acute Leukemias in Susceptible Individuals: Evidence and Discussion

黄曲霉和真菌病毒是易感人群急性白血病的病因:证据与讨论

Tebbi, Cameron K; Sahakian, Eva; Shah, Bijal; Yan, Jiyu; Mediavilla-Varela, Melanie; Patel, Saumil

The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?

Th17细胞在慢性淋巴细胞白血病中的作用:是敌是友?

Gamal, Wael; Sahakian, Eva; Pinilla-Ibarz, Javier

Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies

淋巴系统恶性肿瘤中的调节性T细胞(Tregs)及其对新型疗法的影响

Maharaj, Kamira; Uriepero, Angimar; Sahakian, Eva; Pinilla-Ibarz, Javier

A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention

一项针对组蛋白去乙酰化酶抑制剂帕比司他预防移植物抗宿主病的二期临床试验

Perez, Lia; Fernandez, Hugo; Kharfan-Dabaja, Mohamed; Khimani, Farhad; Betts, Brian; Mishra, Asmita; Ayala, Ernesto; Locke, Frederick L; Ochoa-Bayona, Leonel; Nieder, Michael; Pidala, Joseph; Achille, Alex; Powers, John; Sahakian, Eva; Thapa, Ram; Wang, Xuefeng; Anasetti, Claudio

HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms

HDAC11 缺陷会破坏骨髓增生性肿瘤中癌基因诱导的造血作用

Yue, Lanzhu; Sharma, Vasundhara; Horvat, Nathan P; Akuffo, Afua A; Beatty, Matthew S; Murdun, Cem; Colin, Christelle; Billington, Julia M R; Goodheart, William E; Sahakian, Eva; Zhang, Ling; Powers, John J; Amin, Narmin E; Lambert-Showers, Que T; Darville, Lancia N; Pinilla-Ibarz, Javier; Reuther, Gary W; Wright, Kenneth L; Conti, Chiara; Lee, Jennifer Y; Zheng, Xiaozhang; Ng, Pui Yee; Martin, Matthew W; Marshall, C Gary; Koomen, John M; Levine, Ross L; Verma, Amit; Grimes, H Leighton; Sotomayor, Eduardo M; Shao, Zonghong; Epling-Burnette, Pearlie K

Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells

作者更正:选择性 HDAC6 抑制剂通过降低巨噬细胞的抗炎表型和下调肿瘤细胞中的免疫抑制蛋白,从而改善抗 PD-1 免疫检查点阻断疗法的疗效。

Knox, Tessa; Sahakian, Eva; Banik, Debarati; Hadley, Melissa; Palmer, Erica; Noonepalle, Satish; Kim, Jennifer; Powers, John; Gracia-Hernandez, Maria; Oliveira, Vasco; Cheng, Fengdong; Chen, Jie; Barinka, Cyril; Pinilla-Ibarz, Javier; Lee, Norman H; Kozikowski, Alan; Villagra, Alejandro

A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease

一项针对具有分子疾病证据的慢性粒细胞白血病患者的鲁索替尼联合尼洛替尼的I期临床试验

Sweet, Kendra; Hazlehurst, Lori; Sahakian, Eva; Powers, John; Nodzon, Lisa; Kayali, Fadi; Hyland, Kelly; Nelson, Ashley; Pinilla-Ibarz, Javier